Replies to post #569 on Horizon Therapeutics Public Limited Co (fka HZNP)

[Investor100]

Transactions @ HZNP

Looking forward to the second half of 2015!

On Friday's call with analysts, Chief Business Officer Robert Carey said Horizon still has $500 million it could spend on acquisitions. "We've got sufficient capacity to execute on our plan right now and hope to continue to be active in the marketplace."

http://news.investors.com/050815-751719-hznp-raises-guidance-after-hptx-buyout.htm?ven=yahoocp&src=aurlled&ven=yahoo

Horizon Pharma plc Completes Hyperion Therapeutics Acquisition

Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID(R) 2% From Nuvo Research Inc.

Horizon Pharma completes acquisition of Vidara Therapeutics International LTD

Horizon Pharma announces definitive agreement to acquire Vidara Therapeutics International LTD

Horizon Pharma announces agreement to acquire U.S. rights to VIMOVO

Horizon Therapeutics completes merger with Nitec Pharma

http://www.horizonpharma.com/transactions/

Investor 100